4.3 Article

COPD: Definition and Phenotypes

Journal

CLINICS IN CHEST MEDICINE
Volume 35, Issue 1, Pages 1-+

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ccm.2013.10.010

Keywords

COPD; Definition; Diagnosis; Lung function; Chronic inflammation

Ask authors/readers for more resources

Chronic obstructive pulmonary disease (COPD) is currently defined as a common preventable and treatable disease that is characterized by persistent airflow limitation that is usually progressive and associated with an enhanced chronic inflammatory response in the airways and the lung to noxious particles or gases. Exacerbations and comorbidities contribute to the overall severity in individual patients. The evolution of this definition and the diagnostic criteria currently in use are discussed. COPD is increasingly divided in subgroups or phenotypes based on specific features and association with prognosis or response to therapy, the most notable being the feature of frequent exacerbations.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rehabilitation

Transformations of practice in online exercise training for patients with COPD led by physiotherapists - a qualitative study

Kathrine Rayce, Lotte Huniche, Kristian Kidholm, Jorgen Vestbo, Claus Duedal Pedersen, Lisbeth Rosenbek Minet

Summary: This study characterized telemediated training for COPD patients and found that training at home through telemediation may compromise patient privacy, leading physiotherapists to be more cautious. Therefore, trade-offs need to be considered and continuous adjustments should be made in the practice of telemediated services.

DISABILITY AND REHABILITATION (2022)

Article Respiratory System

The environmental impact of inhaled therapy: making informed treatment choices

Ashley Woodcock, Kai M. Beeh, Hironori Sagara, Simon Aumonier, Emmanuel Addo-Yobo, Javaid Khan, Jorgen Vestbo, Helen Tope

Summary: When selecting inhalers and drugs for respiratory disease, considering the carbon footprint is important. Currently, the most commonly used pMDIs contain potent greenhouse gases, while DPIs and soft mist inhalers have lower carbon footprints. Analyzing the carbon footprint data of inhalers can provide insights for treatment decisions and industry initiatives.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Critical Care Medicine

Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials

Yunus Colak, Borge G. Nordestgaard, Peter Lange, Jorgen Vestbo, Shoaib Afzal

Summary: Most patients with chronic obstructive pulmonary disease are not included in major clinical trials, but they experience significant exacerbations and early death.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Critical Care Medicine

International Differences in the Frequency of Chronic Obstructive Pulmonary Disease Exacerbations Reported in Three Clinical Trials

Peter M. A. Calverley, Fernando J. Martinez, Jorgen Vestbo, Christine R. Jenkins, Robert Wise, David A. Lipson, Nicholas J. Cowans, Julie Yates, Courtney Crim, Bartolome R. Celli

Summary: Countries participating in COPD trials consistently differ in reporting exacerbations, which may explain why large studies are needed to show differences in exacerbation risk reduction between treatments.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Letter Respiratory System

Mortality after admission with pneumonia is higher than after admission with an exacerbation of COPD

Jorgen Vestbo, Grant Waterer, David Leather, Courtney Crim, Nawar Diar Bakerly, Lucy Frith, Loretta Jacques, Catherine Harvey, Imran Satia, Ashley Woodcock

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Potential clinical implications of targeted spirometry for detection of COPD: A contemporary population-based cohort study

Yunus Colak, Borge G. Nordestgaard, Jorgen Vestbo, Shoaib Afzal, Peter Lange

Summary: Targeted spirometry in a general population setting can detect undiagnosed cases of COPD. A significant proportion of individuals with undiagnosed COPD also have other treatable conditions, such as smoking, respiratory symptoms, low physical activity, hypertension, hypercholesterolemia, and diabetes.

RESPIRATORY MEDICINE (2022)

Article Critical Care Medicine

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

Tessa M. Kole, Elise Vanden Berghe, Monica Kraft, Judith M. Vonk, Martijn C. Nawijn, Salman Siddiqui, Kai Sun, Leonardo M. Fabbri, Klaus F. Rabe, Kian Fan Chung, Gabriele Nicolini, Alberto Papi, Chris Brightling, Dave Singh, Thys van der Molen, Sven-Erik Dahlen, Alvar Agusti, Rosa Faner, Jadwiga A. Wedzicha, Gavin C. Donaldson, Ian M. Adcock, Lies Lahousse, Huib A. M. Kerstjens, Maarten van den Berge

Summary: This post-hoc analysis investigates the determinants, clinical implications, and outcome of persistent airflow limitation (PAL) in patients with asthma. The study reveals that PAL is not only present in severe asthma, but also in a considerable proportion of patients with milder disease. In patients with mild asthma, PAL is associated with eosinophilic inflammation and a higher risk of exacerbations, suggesting the need for increased treatment intensity.

LANCET RESPIRATORY MEDICINE (2023)

Article Respiratory System

Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study

Janelle Yorke, Naimat Khan, Adam Garrow, Sarah Tyson, Dave Singh, Jorgen Vestbo, Paul W. Jones

INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2022)

Article Respiratory System

Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis

Efthymia Papadopoulou, Jan Hansel, Zsofia Lazar, Konstantinos Kostikas, Stavros Tryfon, Jurgen Vestbo, Alexander G. Mathioudakis

Summary: This meta-analysis explored the safety and effectiveness of mucolytics as an add-on treatment for COPD exacerbations. The analysis included 24 RCTs involving 2192 patients and showed that mucolytics can increase treatment success rate, improve symptom scores, reduce persistent cough, and facilitate expectoration. There is also some evidence suggesting that mucolytics may reduce future exacerbation risk and improve quality of life.

EUROPEAN RESPIRATORY REVIEW (2023)

Editorial Material Respiratory System

Simplifying pharmacotherapy for patients with COPD: a viewpoint

Bartolome Celli, Jorgen Vestbo

EUROPEAN RESPIRATORY JOURNAL (2023)

Letter Respiratory System

Translated impact on carbon footprint from choice of inhaled therapy: a Danish scenario

Jorgen Vestbo, Kare Press-Kristensen

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Biochemistry & Molecular Biology

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients

Ema Rastoder, Pradeesh Sivapalan, Josefin Ekloef, Imane Achir Alispahic, Alexander Svorre Jordan, Christian B. Laursen, Jorgen Vestbo, Christine Jenkins, Rune Nielsen, Per Bakke, Gustavo Fernandez-Romero, Daniel Modin, Niklas Johansen, Filip Soeskov Davidovski, Tor Biering-Sorensen, Jorn Carlsen, Jens Ulrik Staehr Jensen

Summary: This study compared the efficacy of amlodipine and bendroflumethiazide in treating hypertension in patients with chronic obstructive pulmonary disease (COPD). The results showed that amlodipine use was associated with a reduced risk of death, but had no significant effect on the risk of acute severe exacerbations or hospital admissions.

BIOMEDICINES (2023)

Article Biochemistry & Molecular Biology

Effect of 10-Day Treatment with 50 mg Prednisolone Once-Daily on Haemostasis in Healthy Men-A Randomised Placebo-Controlled Trial

Peter Kamstrup, Ema Rastoder, Pernille Hogh Hellmann, Pradeesh Sivapalan, Emil List Larsen, Jorgen Vestbo, Charlotte Suppli Ulrik, Jens P. Goetze, Filip Krag Knop, Jens Ulrik Staehr Jensen

Summary: Synthetic corticosteroids are commonly used for their anti-inflammatory and immunosuppressant effects, although their association with venous thromboembolism remains unclear. A trial was conducted to investigate the effects of prednisolone on haemostasis in healthy men. The results showed that prednisolone did not affect clot formation but influenced certain prothrombotic markers and antithrombotic markers.

BIOMEDICINES (2023)

Article Respiratory System

Measuring spirometry in a lung cancer screening cohort highlights possible underdiagnosis and misdiagnosis of COPD

Claire Bradley, Panos Alexandris, David R. Baldwin, Richard Booton, Mike Darby, Claire J. Eckert, Rhian Gabe, Neil Hancock, Sam Janes, Martyn Kennedy, Jason Lindop, Richard D. Neal, Suzanne Rogerson, Bethany Shinkins, Irene Simmonds, Sara Upperton, Jorgen Vestbo, Philip A. J. Crosbie, Matthew E. J. Callister

Summary: Spirometry offered alongside LDCT screening can potentially identify cases of undiagnosed and misdiagnosed COPD. Future research should assess the downstream impact of these findings and determine the impact of co-delivering spirometry on other parameters of LDCT screening.

ERJ OPEN RESEARCH (2023)

Meeting Abstract Respiratory System

Prognosis of patients with COPD not eligible for major clinical trials

Y. Colak, B. G. Nordestgaard, P. Lange, J. Vestbo, S. Afzal

EUROPEAN RESPIRATORY JOURNAL (2022)

No Data Available